Disclosure certainty 5/5 debate potential 2/5

Benchling sells professional services with every single customer deal

Sajith Wickramasekara · B2C2B in Digital Health, a founder's playbook · Dec 2, 2021 · at 28:48

Sajith Wickramasekara was not on this episode. A recording of them was played into it, so these are their words but not an appearance on the a16z Podcast. It still counts as said, and it is kept out of every score on their page.

Saji Wickramasekara is the co-founder and CEO of Benchling, a cloud platform for life sciences R&D.

0:00 / 0:04exact quote · 4.5s
▶ Watch the full episode on YouTube → 720p mp4 · rendered on demand · StarZero watermark
“And so we heavily employ services. We sell services with every deal we do.”

quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →

More from Sajith Wickramasekara

Assertion Not checkable as stated
Wickramasekara: 60% of Benchling customers' laboratory instruments are unconnected
“The last time we kind of ran one of these benchmarking exercises was that For our customers, 60% of their instruments are not connected.”
Sajith Wickramasekara Dec 12, 2024 ▶ 10:31 Mastering Your Data with Sajith Wickramasekara
Insight
Wickramasekara: Vertical software markets are less competitive, risking loss of focus
“One thing actually that's probably worse about vertical companies is you, the markets are not as competitive as horizontal companies, and so you can get a little unfocused at times”
Sajith Wickramasekara Dec 12, 2024 ▶ 22:47 Mastering Your Data with Sajith Wickramasekara
Assertion Supported
Wickramasekara: Biologics and advanced modalities now dominate biopharma pipelines
“Biologics, advanced modalities are now majority of the pipeline. We actually have approved cell therapies, gene therapies. We're the first gene editing medicines approved.”
Sajith Wickramasekara Dec 12, 2024 ▶ 4:14 Mastering Your Data with Sajith Wickramasekara
Opinion
Wickramasekara: Pharma researchers do not lack tech literacy
“I think there's sometimes this, like, unfair caricature that people in pharma, like, don't know how to turn on a computer and that the industry just, like, doesn't believe in technology and so forth. I don't think belief in the technology is, like, lacking. I …”
Sajith Wickramasekara Dec 12, 2024 ▶ 5:27 Mastering Your Data with Sajith Wickramasekara
Insight
Wickramasekara: Biological research software requires highly flexible data models
“The data and the technological needs of serving biology are very, very different. You have an incredibly complex multidimensional data model that's happening while the instrumentation lab is now, you know, vastly generating more, more data than ever, ever befo…”
Sajith Wickramasekara Dec 12, 2024 ▶ 5:54 Mastering Your Data with Sajith Wickramasekara
Disclosure
Wickramasekara: Benchling has 800 employees and spends $100M annually on R&D
“We are, 800 people today. We, I think about 40% of our team works in R&D, probably spend a hundred million dollars a year on, on R&D.”
Sajith Wickramasekara Dec 12, 2024 ▶ 6:33 Mastering Your Data with Sajith Wickramasekara
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 1,000 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.